Moreover, the CXCR1/CXCR2 antagonist inhibited CRC liver metastasis by decreasing tumor angiogenesis and facilitating tumor cell apoptosis in a mouse model [83]. The gene discussed is CXCR2; the disease is colorectal carcinoma.